FDA Inspection 1245370 — Main Line Fertility Center
The FDA completed an inspection of Main Line Fertility Center on June 27, 2024 in Bryn Mawr, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 27, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bryn Mawr, PA (United States)